Harbor Investment Advisory LLC decreased its holdings in shares of Teladoc Health, Inc. in the first quarter. (NYSE:TDOC – Get Rating ) by 27.8% during the first quarter, Holdings Channel reports. The institutional investor owned 1,352 shares of the healthcare provider’s stock after selling 520 shares during the period. Harbor Investment Advisory LLC’s holdings in Teladoc Health were worth $98,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds have also made changes to their positions in the company. CarsonAllaria Wealth Management Ltd. bought a new position in shares of Teladoc Health in the fourth quarter worth $30,000. City State Bank bought a new stake in shares of Teladoc Health in the 4th quarter worth about $27,000. Amplius Wealth Advisors LLC bought a new stake in shares of Teladoc Health in the 4th quarter worth about $38,000. Ellevest Inc. raised its stake in Teladoc Health by 133.0% during the 4th quarter. Ellevest Inc. now owns 445 shares of the health services provider’s stock valued at $41,000 after purchasing an additional 254 shares during the period. Finally, Standard Family Office LLC bought a new position in Teladoc Health in the 4th quarter worth about $41,000. 87.17% of the stock is owned by institutional investors and hedge funds.
Shares of Teladoc Health stock opened at $34.83 on Monday. Teladoc Health, Inc. has a one year low of $27.38 and a one year high of $167.50. The company has a debt-to-equity ratio of 0.17, a quick earnings ratio of 3.71 and a current ratio of 3.94. The business has a fifty day moving average of $34.78 and a two hundred day moving average of $59.97. The company has a market cap of $5.61 billion, a P/E ratio of -0.81 and a beta of 0.79.
Teladoc Health (NYSE:TDOC – Get Rating) last posted its earnings results on Wednesday, April 27th. The healthcare provider reported ($0.47) EPS for the quarter, topping analysts’ consensus estimates of ($0.55) by $0.08. Teladoc Health had a negative return on equity of 2.12% and a negative net margin of 321.94%. The company had revenue of $565.35 million during the quarter, compared to the consensus estimate of $568.91 million. During the same quarter last year, the company earned $0.13 earnings per share. Sell-side analysts predict that Teladoc Health, Inc. will post -2.05 EPS for the current year.
TDOC has been the subject of a number of analyst reports. StockNews.com began coverage on shares of Teladoc Health in a research report on Thursday, March 31st. They issued a “sell” rating on the stock. Needham & Company LLC cut their target price on shares of Teladoc Health from $100.00 to $48.00 in a report on Thursday, April 28th. Oppenheimer reduced their target price on shares of Teladoc Health from $130.00 to $65.00 in a report on Thursday, April 28th. Piper Sandler boosted their target price on shares of Teladoc Health from $21.00 to $42.00 in a report on Friday, May 13th. Finally, Citigroup lowered shares of Teladoc Health from a “buy” rating to a “neutral” rating and cut their target price for the stock from $115.00 to $43.00 in a report on Thursday, April 28th. One analyst has rated the stock with a sell rating, eighteen have given a hold rating and nine have issued a buy rating to the company. Teladoc Health presently has a consensus rating of “Hold” and a consensus target price of $87.00, according to MarketBeat.com.
In other news, CFO Mala Murthy sold 4,053 shares of the firm’s stock in a transaction on Monday, June 27th. The shares were sold at an average price of $37.32, for a total value of $151,257.96. Following the completion of the transaction, the chief financial officer now owns 27,295 shares in the company, valued at $1,018,649.40. The sale was disclosed in a filing with the SEC, which is available at this link. Also, SVP Daniel Trencher sold 1,000 shares of the firm’s stock in a transaction on Friday, June 17th. The shares were sold at an average price of $29.12, for a total value of $29,120.00. Following the completion of the transaction, the senior vice president now owns 28,408 shares of the company’s stock, valued at approximately $827,240.96. Disclosure of this sale can be found here. Company insiders own 1.55% of the company’s shares.
Teladoc Healthcare Company Profile (Get Rating)
Teladoc Health, Inc provides virtual health services in the United States and internationally. The company offers a portfolio of services and solutions covering non-emergency, episodic, chronic and complex medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure and mental illness.
Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider deals for Teladoc Health, Inc. (NYSE:TDOC – Get Rating).
Get Teladoc Health Daily news and reviews – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Teladoc Health and related companies with MarketBeat.com ‘s FREE daily email newsletter.